Top Market Shifts Transforming the Breast Cancer Diagnostics Market Landscape: Key Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Breast Cancer Diagnostics Market Through 2025?
The market size for breast cancer diagnostics has experienced robust growth over recent years. The market is projected to expand from $4.68 billion in 2024 to $5.04 billion in 2025, with a compound annual growth rate (CAGR) of 7.9%. The past growth in the market can be linked to factors such as increased public awareness and screening campaigns, advancements in mammography screening, developments in genetic testing, and a multidisciplinary approach.

What's the Projected Size of the Global Breast Cancer Diagnostics Market by 2029?
Substantial expansion is projected for the breast cancer diagnostics market in the upcoming years, reaching a valuation of $6.91 billion in 2029, with a compound annual growth rate (CAGR) of 8.2%. This anticipated growth during the forecast period can be credited to elements such as personalized medicine, liquid biopsies, 3D mammography (tomosynthesis), artificial intelligence, machine learning, telemedicine, and remote consultations. Key trends within this period include improvements in imaging technologies, the rise of personalized medicine, the utilization of liquid biopsies, and the incorporation of AI and machine learning.

View the full report here:
https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

Top Growth Drivers in the Breast Cancer Diagnostics Industry: What's Accelerating the Market?
The rise in breast cancer occurrences will necessitate an increased need for diagnostic tools, intensifying the demand in the breast cancer diagnostics market. Every year, breast cancer, being the most prevalent form of cancer, impacts 2.1 million women and accounts for the highest number of cancer-related deaths among women. The aim of early detection is to raise the frequency of breast cancers identified at a beginning stage, allowing for more effective treatments to be applied, therefore lowering the mortality rate from breast cancer. For example, the American Cancer Society, a US-based health organization dedicated to fighting cancer, reported in January 2022 that approximately 287,850 new cases of invasive breast cancer and 51,400 incidences of DCIS are projected to be diagnosed in women in the United States in 2022, with an expected 43,250 deaths from breast cancer. Consequently, the escalating prevalence of breast cancer is anticipated to propel the growth of the breast cancer diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp

What Trends Will Shape the Breast Cancer Diagnostics Market Through 2029 and Beyond?
The progress in technology is a notable trend in the breast cancer diagnostics market. Numerous novel methods have been established that could be implemented in identifying and treating breast cancer. Breast tomosynthesis, often referred to as 3D mammography, captures images of the breast from several perspectives and constructs them into a 3D model. In September 2022, Niramai, a Health-Tech firm based in India, introduced an innovative solution named Thermalytix. This system, which blends thermal imaging with artificial intelligence, serves as an automated screening and diagnostic tool for breast cancer.

What Are the Main Segments in the Breast Cancer Diagnostics Market?
The breast cancer diagnostics market covered in this report is segmented -

1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types
2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies
3) By Cancer Type: BRCA Breast Cancer, ER And PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types
4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies
5) By End Users: Hospitals And Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers

Subsegments:
1) By Imaging: Mammography, Ultrasound Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Tomosynthesis
2) By Biopsy: Needle Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy (FNA), Stereotactic Biopsy
3) By Genomic Tests: Oncotype DX, MammaPrint, PAM50, BRCA1 Or 2 Testing
4) By Blood Tests: Liquid Biopsy, Circulating Tumor DNA (ctDNA) Tests, Circulating Tumor Cells (CTCs) Tests
5) By Other Types: Hormone Receptor Tests, HER2 Tests, Genetic Mutation Testing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3284&type=smp

Which Top Companies are Driving Growth in the Breast Cancer Diagnostics Market?
Major companies operating in the breast cancer diagnostics market include Abbott Laboratories, Myriad Genetics Inc., Hologic Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fisher Scientific Inc., Siemens AG, NanoString Technologies Inc., Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Micrima Limited, Provista Diagnostics Inc., Leica Biosystems Nussloch GmbH, bioTheranostics Inc., Bio-Rad Laboratories Inc., Illumina Inc., Biocept Inc., Epigenomics AG, AstraZeneca plc, Quest Diagnostics Incorporated, Agilent Technologies Inc., Cepheid, Guardant Health Inc., Invitae Corporation, Natera Inc., NeoGenomics Laboratories Inc., Oncocyte Corporation, PerkinElmer Inc., Sysmex Corporation, Veracyte Inc.

Which Regions Will Dominate the Breast Cancer Diagnostics Market Through 2029?
North America was the largest region in the breast cancer diagnostics market in 2023. Asia-Pacific was the second largest region in the breast cancer diagnostics industry. The regions covered in the breast cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3284

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.